Keeping Current

Neovascular AMD: Optimizing Disease Control for Your Patients

Informações:

Sinopse

When and how to use longer durability therapies in neovascular age-related macular degeneration (nAMD).   Credit available for this activity expires: 10/27/2026 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/1002961?ecd=bdc_podcast_libsyn_mscpedu